APA (7th ed.) Citation

Murray, N. P., Aedo, S., Villalon, R., López, M. A., Minzer, S., Muñoz, L., . . . Guzman, E. (2019). Effect of FOLFOX on minimal residual disease in Stage III colon cancer and risk of relapse. Ecancermedicalscience, 935-961, 1. https://doi.org/10.3332/ecancer.2019.935

Chicago Style (17th ed.) Citation

Murray, Nigel P., et al. "Effect of FOLFOX on Minimal Residual Disease in Stage III Colon Cancer and Risk of Relapse." Ecancermedicalscience 935-961 (2019): 1. https://doi.org/10.3332/ecancer.2019.935.

MLA (9th ed.) Citation

Murray, Nigel P., et al. "Effect of FOLFOX on Minimal Residual Disease in Stage III Colon Cancer and Risk of Relapse." Ecancermedicalscience, 935-961, 2019, p. 1, https://doi.org/10.3332/ecancer.2019.935.